Tay-Sachs disease carrier screening: a model for prevention of genetic disease
- PMID: 10464605
- DOI: 10.1089/gte.1998.2.271
Tay-Sachs disease carrier screening: a model for prevention of genetic disease
Abstract
Tay-Sachs disease (TSD) is an autosomal-recessive, progressive, and ultimately fatal neurodegenerative disorder. Within the last 30 years, the discovery of the enzymatic basis of the disease, namely deficiency of the enzyme hexosaminidase A, made possible both enzymatic diagnosis of TSD and heterozygote identification. In the last decade, the cloning of the HEXA gene and the identification of more than 80 associated TSD-causing mutations has permitted molecular diagnosis in many instances. TSD was the first genetic condition for which community-based screening for carrier detection was implemented. As such, the TSD experience can be viewed as a prototypic effort for public education, carrier testing, and reproductive counseling for avoiding fatal childhood disease. More importantly, the outcome of TSD screening over the last 28 years offers convincing evidence that such an effort can dramatically reduce incidence of the disease.
Similar articles
-
Tay-Sachs disease screening and diagnosis: evolving technologies.DNA Cell Biol. 1993 Oct;12(8):651-65. doi: 10.1089/dna.1993.12.651. DNA Cell Biol. 1993. PMID: 8397824 Review.
-
Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.Genet Epidemiol. 1992;9(3):169-75. doi: 10.1002/gepi.1370090303. Genet Epidemiol. 1992. PMID: 1387862
-
Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.JAMA. 1993 Nov 17;270(19):2307-15. JAMA. 1993. PMID: 8230592
-
Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model.Eur J Pediatr. 2000 Dec;159 Suppl 3:S192-5. doi: 10.1007/pl00014401. Eur J Pediatr. 2000. PMID: 11216898
-
Heterozygote screening for Tay-Sachs disease: past successes and future challenges.Curr Opin Pediatr. 1996 Dec;8(6):625-9. doi: 10.1097/00008480-199612000-00014. Curr Opin Pediatr. 1996. PMID: 9018448 Review.
Cited by
-
Survey on patients' organisations' knowledge and position paper on screening for inherited neuromuscular diseases in Europe.Orphanet J Rare Dis. 2021 Feb 10;16(1):75. doi: 10.1186/s13023-020-01670-8. Orphanet J Rare Dis. 2021. PMID: 33568176 Free PMC article.
-
Genetic Disease and Therapy.Annu Rev Pathol. 2021 Jan 24;16:145-166. doi: 10.1146/annurev-pathmechdis-012419-032626. Annu Rev Pathol. 2021. PMID: 33497260 Free PMC article. Review.
-
Implementing comprehensive genetic carrier screening in China-Harnessing the power of genomic medicine for the effective prevention/management of birth defects and rare genetic diseases in China.Pediatr Investig. 2018 May 11;2(1):30-36. doi: 10.1002/ped4.12021. eCollection 2018 Mar. Pediatr Investig. 2018. PMID: 32851227 Free PMC article. Review.
-
Functional coding and non-coding variants in human BRCA1 gene and their use in genetic screening.Med Oncol. 2019 Jul 3;36(8):71. doi: 10.1007/s12032-019-1294-9. Med Oncol. 2019. PMID: 31270633 Review.
-
Newborn screening and the era of medical genomics.Semin Perinatol. 2015 Dec;39(8):617-22. doi: 10.1053/j.semperi.2015.09.010. Epub 2015 Oct 21. Semin Perinatol. 2015. PMID: 26499764 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials